External Validation of the 2023 Duke–International Society for Cardiovascular Infectious Diseases Diagnostic Criteria for Infective Endocarditis
Clinical Infectious Diseases · 10.04.2024 · 78 (4) · 922-929
DOI: 10.1093/cid/ciae033 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Infectious Diseases, online erschienen am 08.02.2024. Verfasst von Thomas W van der Vaart und 13 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Amsterdam University Medical Center, Universiteit van Amsterdam, Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: Endocarditis, Bacterial, Endocarditis, Communicable Diseases. Die Arbeit wurde bisher 52-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, NIH HHS, Duke Clinical Research Institute.
Abstract (Originalsprache)
Background
The 2023 Duke–International Society of Cardiovascular Infectious Diseases (ISCVID) criteria for infective endocarditis (IE) were introduced to improve classification of IE for research and clinical purposes. External validation studies are required.
Methods
We studied consecutive patients with suspected IE referred to the IE team of Amsterdam University Medical Center (from October 2016 to March 2021). An international expert panel independently reviewed case summaries and assigned a final diagnosis of “IE” or “not IE,” which served as the reference standard, to which the “definite” Duke-ISCVID classifications were compared. We also evaluated accuracy when excluding cardiac surgical and pathologic data (“clinical” criteria). Finally, we compared the 2023 Duke-ISCVID with the 2000 modified Duke criteria and the 2015 and 2023 European Society of Cardiology (ESC) criteria.
Results
A total of 595 consecutive patients with suspected IE were included: 399 (67%) were adjudicated as having IE; 111 (19%) had prosthetic valve IE, and 48 (8%) had a cardiac implantable electronic device IE. The 2023 Duke-ISCVID criteria were more sensitive than either the modified Duke or 2015 ESC criteria (84.2% vs 74.9% and 80%, respectively; P < .001) without significant loss of specificity. The 2023 Duke-ISCVID criteria were similarly sensitive but more specific than the 2023 ESC criteria (94% vs 82%; P < .001). The same pattern was seen for the clinical criteria (excluding surgical/pathologic results). New modifications in the 2023 Duke-ISCVID criteria related to “major microbiological” and “imaging” criteria had the most impact.
Conclusions
The 2023 Duke-ISCVID criteria represent a significant advance in the diagnostic classification of patients with suspected IE.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Infectious Diseases, Amsterdam University Medical Center, Universiteit van Amsterdam, Amsterdam, The Netherlands.
- Division of Infectious Diseases, Duke University Medical Center, Durham, North Carolina, USA.
- Duke Clinical Research Institute, Durham, North Carolina, USA.
- Department of Epidemiology and Data Science, Amsterdam University Medical Center, Universiteit van Amsterdam, Amsterdam, The Netherlands.
- Division of Public Health, Infectious Diseases and Occupational Medicine, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
- Department of Medicine and Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.
ORCID-Profile: Thomas W van der Vaart, Magnus Rasmussen
Förderung
- NIAID NIH HHS
- NIH HHS
- Duke Clinical Research Institute
- Amsterdam University Medical Center
- University Medical Center Utrecht
- Institut d’Investigacions Biomèdiques August Pi I Sunyer
- National Institutes of Health
Zitieren
APA
van der Vaart, T. W., Bossuyt, P. M. M., Durack, D. T., Baddour, L. M., Bayer, A. S., Durante-Mangoni, E., Holland, T. L., Karchmer, A. W., Miro, J. M., Moreillon, P., Rasmussen, M., Selton-Suty, C., Fowler, V. G., & van der Meer, J. T. M. (2024). External Validation of the 2023 Duke–International Society for Cardiovascular Infectious Diseases Diagnostic Criteria for Infective Endocarditis. Clinical Infectious Diseases, 78(4), 922-929. https://doi.org/10.1093/cid/ciae033
Vancouver
van der Vaart TW, Bossuyt PMM, Durack DT, Baddour LM, Bayer AS, Durante-Mangoni E, et al. External Validation of the 2023 Duke–International Society for Cardiovascular Infectious Diseases Diagnostic Criteria for Infective Endocarditis. Clinical Infectious Diseases. 2024;78(4):922-929. doi:10.1093/cid/ciae033
BibTeX
@article{vanderVaart2024,
author = {van der Vaart, Thomas W and Bossuyt, Patrick M M and Durack, David T and Baddour, Larry M and Bayer, Arnold S and Durante-Mangoni, Emanuele and Holland, Thomas L and Karchmer, Adolf W and Miro, Jose M and Moreillon, Philippe and Rasmussen, Magnus and Selton-Suty, Christine and Fowler, Vance G and van der Meer, Jan T M},
title = {External Validation of the 2023 Duke–International Society for Cardiovascular Infectious Diseases Diagnostic Criteria for Infective Endocarditis},
journal = {Clinical Infectious Diseases},
year = {2024},
volume = {78},
number = {4},
pages = {922--929},
doi = {10.1093/cid/ciae033}
}
EUVIMED